The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Pharma Lessons from the PTAB: Litigation and Prosecution" on June 8, 2017 from 2:00 to 3:00 pm (ET). Eldora Ellison of Sterne Kessler Goldstein & Fox, PLLC; Cynthia Lambert Hardman of Goodwin Procter LLP; and Kerry Taylor of Knobbe, Martens, Olson & Bear LLP will spell out winning strategies specific to the biopharmaceutical industry for both patent owners and challengers, and will also highlight lessons for patent prosecutors that emerge from PTAB practice. Topics to be discussed include:
• The role of objective indicia of nonobviousness. Pharma patents do put up a better fight at the PTAB than other technologies: last year, a third of biotech/pharma claims survived PTAB trials, almost three times the survival rate of electrical/computer claims;
• The surge in PGRs challenges to pharma patents on Section 112 grounds of indefiniteness and enablement;
• The relationship between district court Hatch-Waxman litigation and PTAB challenges;
• How to inoculate continuations or divisionals of challenged patents to relevant prior art.
The registration fee for the webinar is $135 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.
Comments